Login
Login

Category: Regulatory/FDA

CHC_DTCadvertisement2

Two Recent OPDP Letters Prompted by “Bad Ad Program” Complaints

Learn More
CHC_general1

OPDP Focuses on Misleading Opioid Claims Amid National Crisis

Learn More
vaccine.News

FDA Plans Expedited Approval Path for Modified COVID-19 Vaccines

Learn More
FDA-News (1)

Woodcock to Take Helm While Biden Considers FDA Commissioner Choice

Learn More
FDA 2020.news

Despite Strain on Resources During Pandemic, CDER Approves 53 Novel Drugs in 2020

Learn More
Nancy Myers.NEWS

Myers: What the FDA Might Look Like Under Biden

Learn More
fda-logo

Azurity Email Garners OPDP Enforcement Letter for False/Misleading Claims

Learn More
oig_hhs_logoNEWS

HHS OIG Releases Fraud Alert on Speakers Bureaus

Learn More
Abrams_Tom.NEWS

OPDP Director Tom Abrams Retires, Leaving Mark on Drug Promotion Regulation

Learn More